Some partnerships feel inevitable. After nearly two decades of collaboration, Shaily is proud to welcome Stefan Bohling, a globally respected authority in medical device development and commercialisation, as an exclusive Consultant and Advisory Board Member to its healthcare division.
With more than 30 years at the forefront of medical device innovation, Stefan has helped shape products that millions of patients around the world rely on every day. At Sanofi, he and his teams brought to life globally recognised drug delivery devices including the SoloStar®, AllStar®, and Lyxumia® pens, as well as autoinjectors, connectivity solutions, and pioneering work in sustainable device design.
This appointment continues a trusted relationship built over many years. Stefan has been a client, collaborator, and friend of Shaily for almost two decades, and stepping into this new role is the natural next chapter in that journey. Alongside his technical expertise, he brings a passion for mentoring, guiding, and inspiring teams, ensuring knowledge is passed on to strengthen Shaily’s capabilities for years to come.
Amit Sanghvi, Managing Director of Shaily, said, “With demand for drug delivery systems increasing worldwide, we are delighted to welcome Stefan to the Shaily family. His expertise in device development and industrialisation, along with his understanding of markets, customers, and competitors, will be invaluable as we shape future strategies and drive new innovation. Having worked closely with him for many years, I know the insight and passion he brings, and we are excited to have him support the next stage of Shaily’s journey.”
With design and innovation studios in the UK and large-scale manufacturing facilities in India, Shaily offers a unique global platform that blends creativity with scale. Stefan’s arrival strengthens this capability, helping to ensure that future drug delivery devices combine innovation, quality, and reliability at every stage.
Stefan Bohling added, “I am honoured to join the Shaily team and excited to contribute to their journey of advancing high-performance, sustainable medical devices. Shaily’s energy and commitment to quality and innovation are inspiring, and I look forward to working together to deliver solutions that truly make a difference for patients worldwide.”
About Shaily:
Established in 1987, Shaily provides end-to-end solutions in plastic products and services. With over 2000 employees across seven manufacturing units, it has over 200 injection moulding machines with precise, high speed automated and robotic production lines.
Shaily manufactures and supplies goods to some of the biggest names across various industries and its exceptionally high quality standards enables it to supply products for the medical, healthcare and consumer sectors, as well as critical components for the automotive industry.
